USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: Invitron Corp
Address: 4649 Le Bourget Dr
Saint Louis, MO 63134
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $200,000.00 4
SBIR Phase II $881,000.00 2

Award List:

PARATHYROID IMAGING BY RADIOLABELED MONOCLONAL ANTIBODY

Award Year / Program / Phase: 1986 / SBIR / Phase I
Agency: HHS
Principal Investigator: Charles Benton , Principal Investigator
Award Amount: $50,000.00

CHARACTERIZATION AND EXPRESSION OF CDNA CLONES ENCODING HUMAN PROTEASE NEXIN

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Michael p mcgrogan phd
Award Amount: $50,000.00
Abstract:
Protease nexin (pn), cdna clones were isolated from a human fibroblast library using oligomer probes derived from the n-terminal amino acid sequence of the protein. several full-length clones were characterized and found to be approximately 2,100 bp long. the pn clones contained a 1,260 bp… More

IMMUNOSORBENT DEVICE FOR LDL REMOVAL FROM WHOLE BLOOD

Award Year / Program / Phase: 1987 / SBIR / Phase I
Agency: HHS
Principal Investigator: Laura H Silberstein Phd
Award Amount: $50,000.00

PARATHYROID IMAGING BY RADIOLABELED MONOCLONAL ANTIBODY

Award Year / Program / Phase: 1988 / SBIR / Phase II
Agency: HHS
Principal Investigator: Charles Benton , Principal Investigator
Award Amount: $500,000.00
Abstract:
The goal of this project is to develop a monoclonal antibody-based imaging reagent capable visualizing human parathyroidglands. the study will be directed at isolation and characterization of human parathyroid-specific mouse monoclonal antibodies and preliminary analysis of their target antigens. as… More

IMMUNOSORBENT DEVICE FOR LDL REMOVAL FROM WHOLE BLOOD

Award Year / Program / Phase: 1988 / SBIR / Phase II
Agency: HHS
Principal Investigator: Laura H Silberstein Phd
Award Amount: $381,000.00
Abstract:
High blood levels of ldl have been established as causative for atherosclerosis and coronary heart disease. for selected patients, extracorporeal ldl removal is the most effective therapy. the goal of this project is to develop amonoclonal antibody-based immunoadsorption device capable of removing… More

IMMORTALIZATION OF HUMAN CELLS

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Studies of the regulation of cell growth and of oncogenic transformation have revealed key roles for viral transforming genes as well as for external growth and differentiation factors. certain viral genes have been used in the transformation of primary cells to immortality in culture, and… More